Literature DB >> 6804578

A plasmid-mediated cephalosporinase from Achromobacter species.

R Levesque, P H Roy, R Letarte, J C Pechère.   

Abstract

An unusual cephalosporinase in Achromobacter species was characterized biochemically; the enzyme had a pI of 8.1 and a molecular mass of 36,200 daltons, and it was not inhibited by p-chloromercuribenzoate or cloxacillin. Specific antiserum neutralized enzymatic activity. Agarose gel electrophoresis of the DNA of two strains (MULB 906 and MULB 912) revealed at least three plasmid bands; cured strains demonstrated a simultaneous loss of beta-lactamase and plasmid DNA. Resistance to beta-lactam antibiotics was transferred by transformation of Escherichia coli strain HB101 with plasmid DNA. This plasmid-mediated beta-lactamase differed from the two types of chromosomal cephalosporinases (pI 7.4 and 9.3, respectively) found in a survey of clinical isolates of Achromobacter species. This enzyme also differed in its biochemical properties from all of the other known plasmid-mediated beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804578     DOI: 10.1093/infdis/145.2.753

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 2.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

Review 3.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  Evolutionary perspectives on multiresistance beta-lactamase transposons.

Authors:  M Lafond; F Couture; G Vézina; R C Levesque
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

5.  Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes.

Authors:  R C Levesque; A A Medeiros; G A Jacoby
Journal:  Mol Gen Genet       Date:  1987-02

6.  Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.

Authors:  Cristina Pichardo; José Manuel Rodríguez-Martínez; María E Pachón-Ibañez; Carmen Conejo; José Ibáñez-Martínez; Luis Martínez-Martínez; Jerónimo Pachón; Alvaro Pascual
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

8.  Identification of an inducible penicillinase of the lithoautotrophic hydrogen-oxidizing bacterium Alcaligenes eutrophus.

Authors:  P Sebo; J Stastná
Journal:  Folia Microbiol (Praha)       Date:  1987       Impact factor: 2.099

9.  Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.

Authors:  J C Pechère
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila.

Authors:  R W Hedges; A A Medeiros; M Cohenford; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.